Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model

Managing endovascular thrombectomy (ET) in diabetic ischemic stroke (IS) with novel anticoagulants is challenging due to putative risk of intracerebral hemorrhage. The study evaluates increased hemorrhagic transformation (HT) risk in Rivaroxaban-treated diabetic rats post ET. Diabetes was induced in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Feng-Di, Zhao, Rong, Feng, Xiao-Yan, Shi, Yan-Hui, Wu, Yi-Lan, Shen, Xiao-Lei, Li, Ge-Fei, Liu, Yi-Sheng, Zhao, Ying, He, Xin-Wei, Yin, Jia-Wen, Zhuang, Mei-Ting, Zhao, Bing-Qiao, Liu, Jian-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943582/
https://www.ncbi.nlm.nih.gov/pubmed/29743683
http://dx.doi.org/10.1038/s41598-018-25820-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943582/
https://www.ncbi.nlm.nih.gov/pubmed/29743683
http://dx.doi.org/10.1038/s41598-018-25820-y

Ejemplares similares